Tech

(Henry Ford Health System) NeuroTrauma Sciences, LLC (NTS), a biopharmaceutical company, and Henry Ford Health System, a non-profit organization, today announce that a newly-formed subsidiary of NTS has entered into multi-year Sponsored Research and License Agreements. The new company is named NeurExo Sciences, LLC (NXS) and its goal is to advance Henry Ford's pioneering technology involving exosomes as extracellular vesicles enriched with microRNA for the purpose of treating stroke, traumatic brain injury (TBI) including concussion, and neuropathies.
July 16, 2018
(University of Akron) Researchers will model response of colon cancer cells to anticancer drugs using 3D cultures. By exploring specific mechanisms of a cancer cell's feedback signaling that renders tumors non-responsive, they can design treatment strategies that effectively block tumor growth with significantly reduced toxicity to normal cells.
July 13, 2018
(University of Washington Health Sciences/UW Medicine) Ultrasonic repositioning of kidney stones will be tested in emergency department patients at UW Medicine as part of the development of a new medical technology for NASA. Astronauts are prone to kidney stones during space missions. The hope is that pushing stones with an ultrasound tractor beam would offer pain relief and avoid medical complications of urinary backups for astronauts affected in space.
July 13, 2018
(Tokyo Institute of Technology) Researchers at Tokyo Institute of Technology have developed a ruthenium-based perovskite catalyst that shows strong activity even at low temperatures (down to 313 K). The reusable catalyst does not require additives, meaning that it can prevent the formation of toxic by-products. The oxidation of sulfides is a commercially important process with broad applications ranging from chemicals production to environmental management.
July 13, 2018
(The Francis Crick Institute) Scientists have developed a method to measure how well cancer drugs reach their targets inside the body. It shows individual cancer cells in a tumor in real time, revealing which cells interact with the drug and which cells the drug fails to reach. The findings could help clinicians decide the best course and delivery of treatment for cancer patients in the future.
July 12, 2018
(University of Basel) Electrical circuits are constantly being scaled down and extended with specific functions. A new method now allows electrical contact to be established with simple molecules on a conventional silicon chip. The technique promises to bring advances in sensor technology and medicine, as reported in the journal Nature by chemists from the University of Basel and researchers from IBM Research-Zurich in Rüschlikon.
July 12, 2018